BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 169861)

  • 21. Studies on the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Protection against tumor isografts.
    Weiss DW; Bonhag RS; Leslie P
    J Exp Med; 1966 Dec; 124(6):1039-65. PubMed ID: 4288701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoimmunotherapy of syngeneic mouse mammary carcinomas employing methanol extraction residue.
    Cohen D; Yron I; Grover NB; Weiss DW
    Ann N Y Acad Sci; 1976; 277(00):195-208. PubMed ID: 793479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCG and cancer (first of two parts).
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(25):1413-20. PubMed ID: 4364286
    [No Abstract]   [Full Text] [Related]  

  • 24. Protection against guinea pig hepatomas by pretreatment with subcelluar fractions of Mycobacterium bovis (BCG).
    Minden P; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 May; 52(5):1643-5. PubMed ID: 4364739
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumour inhibition mediated by BCG in immunosuppressed rats.
    Moore M; Lawrence N; Nisbet NW
    Int J Cancer; 1975 Jun; 15(6):897-911. PubMed ID: 1150345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 27. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 28. Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma.
    Bast RC; Zbar B; Miller TE; Mackaness GB; Rapp HJ
    J Natl Cancer Inst; 1975 Mar; 54(3):757-61. PubMed ID: 164568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL; Kreider JW; Purnell DM
    J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG.
    Harmel RP; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
    Zbar B; Ribi E; Meyer T; Azuma I; Rapp HJ
    J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736
    [No Abstract]   [Full Text] [Related]  

  • 32. Induction of tumor resistance with BCG-associated tumor antigen.
    Crum ED; McGregor DD
    Int J Cancer; 1977 Nov; 20(5):805-12. PubMed ID: 200576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA; Kleinerman J; Saidel GM
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T; Tokunaga T; Murohashi T
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of methanol extraction residue and therapeutic irradiation against established isografts and simulated local recurrence of mammary carcinomas.
    Yron I; Cohen D; Robinson E; Haber M; Weiss DW
    Cancer Res; 1975 Jul; 35(7):1779-90. PubMed ID: 1093676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of transplanted sarcomas mediated by BCG in rats with a defined immunological deficit.
    Moore M; Lawrence N; Nisbet NW
    Biomedicine; 1976 Jan; 24(1):26-31. PubMed ID: 773443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic effect of intratumoral injection of bcg and other substances in rats and mice.
    Chassoux D; Salomon JC
    Int J Cancer; 1975 Oct; 16(4):515-25. PubMed ID: 1176205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of polyoma tumor metastasis by combined unblocking and BCG treatment--correlation with induced alterations in tumor immunity status.
    Bansal SC; Sjögren HO
    Int J Cancer; 1973 Jul; 12(1):179-93. PubMed ID: 4597859
    [No Abstract]   [Full Text] [Related]  

  • 40. Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy.
    Mathé G; Hiu IJ; Halle-Pannenko O; Bourut C
    Isr J Med Sci; 1976; 12(4-5):468-71. PubMed ID: 820673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.